MDS Pharma Services Hires Beverly Harrison to Lead North American Clinical Operations from its King of Prussia Executive Offices MONTREAL, Oct. 4 /PRNewswire-FirstCall/ -- MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has hired Beverly Harrison as vice president for Clinical Operations in North America. Based at the King of Prussia, Pa., office, her addition to the leadership team is a key milestone in MDS Pharma Services' efforts to expand its Late State business in North America. "Beverly's extensive industry experience, coupled with her skills in strategic planning and change management, will augment our strong management team in clinical operations and provide leadership as we expand our business in North America, particularly in the United States," says Alan Horgan, group vice president, Late Stage Development. "Our commitment to the U.S. region is demonstrated by the addition of someone of Beverly's caliber to our team." Prior to joining MDS Pharma Services, Harrison was president of Trilliant Research Inc. of Marlton, N.J., and vice president for Business Development and chief business officer at Premier Research in Philadelphia, Pa. She played a key role in facilitating Premier's acquisition of Trilliant in 2003. Harrison's experience also includes executive positions at Covance Inc. in Princeton, N.J., and clinical research project management for Smith Kline Beckman (now GlaxoSmithKline) in Philadelphia. MDS Pharma Services offers a full spectrum of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With numerous facilities strategically located around the world, the company applies advanced scientific and technological expertise to each stage of the drug discovery and development process -- early stage: lead optimization, pre-IND research, pharmaceutical and biopharmaceutical development, early clinical research (bioequivalence, phases I-IIa) and bioanalysis; and late stage: global clinical development (phases IIb-IV) and central lab. For more information, visit MDS Pharma Services' Web site at http://www.mdsps.com/. MDS Pharma Services is part of MDS Inc. (TSX: MDS; NYSE: MDZ), an international health and life sciences company. At MDS Inc., our 10,000 highly skilled people provide services, products and instruments enabling health sciences organizations to enhance the well being of people around the world. We focus on helping discover and test new drugs, assisting doctors to diagnose and treat patients and preventing the spread of disease. Find out more about MDS Inc. (TSX: MDS; NYSE: MDZ), at http://www.mdsintl.com/ or by calling 1-888-MDS-7222, 24 hours a day. DATASOURCE: MDS Pharma Services CONTACT: or to receive a high-resolution photograph of Beverly Harrison suitable for print reproduction, please contact Charlene McGrady, MDS Pharma Services, 2200 Renaissance Boulevard, King of Prussia, Pa., Tel: (610) 239-7900, ext. 231, and visit our Web site at http://www.mdsps.com/.

Copyright